Nexalin Technology, Inc. splits its revenue into 5 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Device Sales at $136,000, 45% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
|---|---|---|---|---|---|
| Revenue |
0
|
0
|
0
|
0
|
1
|
| Device Sales |
—
|
0
+145.0%
share 45.1%
|
0
share 32.9%
|
—
|
1
share 88.1%
|
| Equipment |
—
|
0
+135.4%
share 29.5%
|
0
+38.6%
share 22.4%
|
0
+1.9%
share 24.6%
|
0
share 2.0%
|
| Licensing Fee |
—
|
0
-29.3%
share 16.3%
|
0
-15.3%
share 41.2%
|
0
+3.7%
share 74.1%
|
0
share 6.0%
|
| Other |
—
|
0
+366.4%
share 9.1%
|
0
+330.5%
share 3.5%
|
0
-94.8%
share 1.2%
|
0
share 2.0%
|
| Royalty Fee |
—
|
—
|
—
|
—
|
0
share 1.9%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- NXL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1527352
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.